1 December 2025 false No description of principal activity Taxfiler 2024.6 08226415business:PrivateLimitedCompanyLtd2025-12-012026-10-31 082264152025-11-30 082264152025-12-012026-10-31 08226415business:AuditExempt-NoAccountantsReport2025-12-012026-10-31 08226415business:FilletedAccounts2025-12-012026-10-31 082264152026-10-31 08226415business:Director12025-12-012026-10-31 08226415business:RegisteredOffice2025-12-012026-10-31 082264152025-11-30 08226415core:WithinOneYear2026-10-31 08226415core:WithinOneYear2025-11-30 08226415core:ShareCapitalcore:PreviouslyStatedAmount2026-10-31 08226415core:ShareCapitalcore:PreviouslyStatedAmount2025-11-30 08226415core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2026-10-31 08226415core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-11-30 08226415core:PreviouslyStatedAmount2026-10-31 08226415core:PreviouslyStatedAmount2025-11-30 08226415business:SmallEntities2025-12-012026-10-31 08226415countries:EnglandWales2025-12-012026-10-31 08226415core:PlantMachinery2025-12-012026-10-31 08226415core:ComputerEquipment2025-12-012026-10-31 08226415core:PlantMachinery2025-11-30 08226415core:ComputerEquipment2025-11-30 08226415core:PlantMachinery2026-10-31 08226415core:ComputerEquipment2026-10-31 082264152024-12-012025-11-30 iso4217:GBP xbrli:pure
Company Registration No. 08226415 (England and Wales)
Alpharma Limited Unaudited accounts for the period from 1 December 2025 to 31 October 2026
Alpharma Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Alpharma Limited Company Information for the period from 1 December 2025 to 31 October 2026
Director
M Issat
Company Number
08226415 (England and Wales)
Registered Office
195-197 OTLEY ROAD BRADFORD WEST YORKSHIRE BD3 0JF
- 3 -
Alpharma Limited Statement of financial position as at 31 October 2026
2026 
2025 
Notes
£ 
£ 
Fixed assets
Tangible assets
4
1,726 
2,157 
Current assets
Debtors
5
42,265 
42,838 
Cash at bank and in hand
34 
739 
42,299 
43,577 
Creditors: amounts falling due within one year
6
(48,827)
(49,028)
Net current liabilities
(6,528)
(5,451)
Net liabilities
(4,802)
(3,294)
Capital and reserves
Called up share capital
150 
150 
Profit and loss account
(4,952)
(3,444)
Shareholders' funds
(4,802)
(3,294)
For the period ending 31 October 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 2 November 2026 and were signed on its behalf by
M Issat Director Company Registration No. 08226415
- 4 -
Alpharma Limited Notes to the Accounts for the period from 1 December 2025 to 31 October 2026
1
Statutory information
Alpharma Limited is a private company, limited by shares, registered in England and Wales, registration number 08226415. The registered office is 195-197 OTLEY ROAD, BRADFORD, WEST YORKSHIRE, BD3 0JF.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous period, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
20% reducing balance
Computer equipment
50% straight line
4
Tangible fixed assets
Plant & machinery 
Computer equipment 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 December 2025
8,201 
11,226 
19,427 
At 31 October 2026
8,201 
11,226 
19,427 
Depreciation
At 1 December 2025
6,044 
11,226 
17,270 
Charge for the period
431 
- 
431 
At 31 October 2026
6,475 
11,226 
17,701 
Net book value
At 31 October 2026
1,726 
- 
1,726 
At 30 November 2025
2,157 
- 
2,157 
5
Debtors
2026 
2025 
£ 
£ 
Amounts falling due within one year
VAT
- 
573 
Other debtors
42,265 
42,265 
42,265 
42,838 
- 5 -
Alpharma Limited Notes to the Accounts for the period from 1 December 2025 to 31 October 2026
6
Creditors: amounts falling due within one year
2026 
2025 
£ 
£ 
Other creditors
36,750 
36,200 
Loans from directors
11,497 
11,168 
Accruals
580 
1,660 
48,827 
49,028 
7
Average number of employees
During the period the average number of employees was 3 (2025: 3).
- 6 -